In the early and mid-1980s, scientists used phages to express recombinant proteins. The protein was retained inside the virions, so screening required growing viral plaques, creating a stamp of these ...
The human CD81 (hCD81), the most recently proposed receptor of hepatitis C virus (HCV), can especifically bind to HCV envelope glycoprotein 2 (E2). In this study, hCD81-expressing murine NIH/3T3 cells ...
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug ...
With multidrug resistant (MDR) infections on the rise worldwide, researchers have started looking at using bacteriophages – viruses that only infect bacteria – as an alternative to a dwindling arsenal ...
Reviewed by Michael Greenwood, M.Sc. In phage-display, a gene encoding the surface protein of a bacteriophage is replaced with a gene encoding a novel protein. The technique can be used in drug ...
Phage display is an analytical technique used to study protein-protein interactions and the relationship between a protein and the encoding DNA. Phage display begins by incorporating the protein of ...
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced that the ...
Adaptive Phage Therapeutics, a clinical-stage company that develops phage therapeutics to counter multidrug-resistant pathogenic bacteria, operates Biosafety Level 2 laboratories and phage ...
Serological tests, also known as “antibody tests,” are one of the foundations of clinical medicine, with a particularly important role in infectious disease. They can detect active infections, but can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback